Join our Community
Support ToI and remove all ads
Learn more

ISRAEL AT WAR - DAY 560

clinical trials

A Teva Pharmaceuticals logistics center in Shoham, January 7, 2021. (Yossi Aloni/ Flash90)
December 17, 2024, 11:51 pm
Teva soars on ‘positive’ trial results for inflammatory bowel disease treatment
Patients treated with antibody ‘duvakitug,’ jointly developed with French drug-maker Sanofi, achieved a higher rate of clinical remission
By Sharon Wrobel
Illustrative: A scientist sits at his desk and consults an engineer about sophisticated coding and programming at a computer science research laboratory. (iStock by Getty Images)
October 24, 2023, 8:36 pm
In times of war, Israeli startup nabs $15m to help optimize clinical trials
PhaseV says its machine learning platform helps clinical development teams analyze and design studies to speed up drug development
By Sharon Wrobel
File: This video grab made from the online Neuralink livestream shows a drawing of the different steps of the implantation of a Neuralink brain implant device seen during a presentation on August 28, 2020. (Neuralink/AFP)
September 20, 2023, 10:12 pm
Musk’s Neuralink starts recruiting volunteers to test brain implants
Firm seeking individuals with mobility diseases for first human clinical trial of technology that aims to use brain to control computers, and one day treat neurological disorders
By ToI Staff and AFP
Illustrative: A scientist sits at his desk and consults an engineer about sophisticated coding and programming at a computer science research laboratory. (iStock by Getty Images)
August 30, 2023, 8:27 pm
Israeli startup raises $15 million to drive US expansion of clinical trial simulator
QuantHealth says its AI platform can predict results with 86% accuracy and support the success of faster, cheaper drug discovery and development
By Sharon Wrobel
A preterm neonate with a nasogastric tube in an incubator. (Courtesy of Elgan Pharma)
August 29, 2023, 11:33 am
Israeli company nears final hurdle to okay insulin-based preemie therapy
Elgan Pharma uses insulin’s growth factor properties to help the gastrointestinal systems of the tiniest babies develop more quickly and effectively — and get them home sooner
By Renee Ghert-Zand
Illustrative image: a doctor holds up a pink ribbon for breast cancer awareness. (dragana991 via iStock by Getty Images)
April 18, 2023, 7:59 am
Women with breast cancer genetic marker hope osteoporosis drug could halt disease
Shaare Zedek Medical Center participates in international long-term clinical trial of Denosumab, which investigators say may offer medical alternative to preventive mastectomy
By Renee Ghert-Zand
Benny Landsman, 4, at Dayton Children’s Hospital April 8, 2021, before surgery to receive the first clinical trial of a new gene therapy for Canavan disease. (Courtesy of the Landsman family/ via Dayton Jewish Observer)
May 8, 2021, 3:46 am
New gene therapy trial in US offers hope for children with Canavan disease
4-year-old Benny Landsman is first to receive experimental procedure for condition that causes blindness, paralysis, seizures, and average life expectancy of under a decade
By Marshall Weiss
Prime Minister Benjamin Netanyahu (C) and Defense Minister Benny Gantz (R) speak with Segev Harel, the first volunteer for trials for an experimental Israeli coronavirus vaccine, at Sheba Medical Center, November 1, 2020. (Ariel Hermoni/Defense Ministry)
February 3, 2021, 2:22 pm
First volunteer for Israeli vaccine trials, feted by Netanyahu, got the placebo
Segev Harel, who received much media attention for being 1st to take part in experiment of homegrown inoculation Brilife, says he has since learned he was in the control group
By ToI Staff
A researcher in a laboratory at the Jenner Institute in Oxford, England, works on the coronavirus vaccine developed by AstraZeneca and Oxford University, November 23, 2020. (University of Oxford/John Cairns via AP, File)
November 26, 2020, 11:05 am
AstraZeneca facing questions about vaccine after admitting to testing error
Manufacturing glitch casts shadow on results of study after British drug group and Oxford university said lower dose of inoculation provides better protection from virus
By AP and ToI Staff
Segev Harel, the first volunteer for trials for Israel's coronavirus vaccine. (Sheba Medical Center)
October 31, 2020, 11:28 pm
Volunteer to receive 1st Israeli vaccine shot hails ‘historic opportunity’
Segev Harel, 26, tapped to get COVID-19 shot at Sheba Hospital on Sunday as clinical trial gets underway
By Nathan Jeffay and ToI Staff
Prof. Boaz Lerner of Ben-Gurion University and the software being developed by Panacea (Dani Machlis)
October 28, 2020, 1:08 pm
Israeli researchers wield machine learning to streamline clinical trials
Ben-Gurion University licenses tech to startup Panacea for further development; several biopharma firms seeking to use platform to improve how clinical trials are run
By Jake Epstein
Jodie Cohen
August 9, 2020, 4:16 pm
Jodie Cohen
Some potentially positive COVID news?
The Israeli Institute of Biological research has announced that it is expecting to start testing its potential COVID-19 vaccine on humans in October
A subject receives a shot in the first-stage safety study clinical trial of a potential vaccine by Moderna for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle, March 16, 2020. (AP/Ted S. Warren, File)
July 27, 2020, 4:09 am
US vaccine firm: Human trials could be held in Israel as infection rates rise
After Jerusalem signed binding term sheet for purchase of drug, CEO of Arcturus Therapeutics says Phase 3 study needs to be held in location with substantial number of cases
By ToI Staff
A syringe injects an illustrated representation of COVID-19, the disease caused by the novel coronavirus, in Paris, on May 18, 2020. (JOEL SAGET/AFP)
July 23, 2020, 8:34 pm
Israel said expected to ink deal with US firm developing COVID-19 vaccine
TV reports country to buy four million units of drug made by Arcturus Therapeutics and Singapore’s Duke-NUS medical school, recently granted permission to begin clinical trials
By ToI Staff and Agencies
Gamida Cell's lab manager Noga Goudsmid-Rosenheimer at work, July 16, 2017 (Shoshanna Solomon/Times of Israel)
May 12, 2020, 4:32 pm
Cell therapy firm boosts odds for blood cancer patients as key trial succeeds
Jerusalem’s Gamida Cell says ‘lifesaving’ stem-cell therapy helps increase success of bone marrow transplants; firm hopes to launch treatment in US in second half of 2021
By Shoshanna Solomon
Load More
Sign in or Register
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering also lets you comment on articles and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.